Skip to main content
ARECOR THERAPEUTICS PLC logo

ARECOR THERAPEUTICS PLC — Investor Relations & Filings

Ticker · AREC ISIN · GB00BMWLM973 LEI · 98450093D12I3A8DDD58 IL Manufacturing
Open in API
Filings indexed 199 across all filing types
Latest filing 2026-05-21 Director's Dealing
Country GB United Kingdom
Listing IL AREC

About ARECOR THERAPEUTICS PLC

https://arecor.com/

Arecor Therapeutics plc is a clinical-stage biopharmaceutical company focused on developing enhanced therapeutic medicines. The company utilizes its proprietary Arestat® technology platform, a formulation science designed to improve the properties of proteins and peptides, enabling superior drug product profiles. Arecor's business model involves two approaches: developing an internal portfolio of proprietary products and partnering with pharmaceutical and medtech companies to enhance their therapeutic offerings. The company's in-house development pipeline is primarily focused on advancing treatments for diabetes and other cardiometabolic diseases, including next-generation insulin candidates.

Recent filings

Filing Released Lang Actions
Grant of options and PDMR dealing
Director's Dealing Classification · 95% confidence The document is an RNS announcement detailing the grant of share options to PDMRs (senior executives) and includes the notifications required under the Market Abuse Regulation for directors’ dealings. This clearly falls under insider share transactions by company directors, which corresponds to the “Director’s Dealing” category.
2026-05-21 English
Upcoming conference attendance
Regulatory Filings Classification · 80% confidence The document is a short RNS press release announcing the company’s attendance at upcoming industry conferences (ADA Scientific Sessions and BIO International Convention). It contains no financial data, no voting or meeting results, no regulatory filings beyond the press notice itself, nor any substantive report. It falls under general regulatory announcements, so the appropriate classification is the fallback category Regulatory Filings (RNS).
2026-05-18 English
Group of companies' accounts made up to 2025-12-31
Annual Report Classification · 95% confidence The document is titled “Annual Report and Accounts for the year ended 31 December 2025” and includes a full Strategic Report, Corporate Governance section, independent auditor’s report, consolidated and company financial statements with detailed notes. It is a comprehensive yearly report covering company activities and full financial performance. Therefore, it is classified as an Annual Report (10-K). FY 2025
2026-05-11 English
Posting of Annual Report and Notice of AGMm
Report Publication Announcement Classification · 95% confidence The document is a short RNS announcement (4,406 characters) stating that the company has published and posted its Annual Report and Accounts and the Notice of AGM, and provides links and details on how to access them. It does not contain the report itself but is an announcement of publication. Under the “menu vs meal” rule, this is a Report Publication Announcement.
2026-04-28 English
Final Results
Earnings Release Classification · 85% confidence The document is an RNS announcement of Arecor Therapeutics plc’s audited full year results for the 12 months ended 31 December 2025. It provides operational and financial highlights, CEO/Chair commentary, and details of a webcast, but does not contain the full set of financial statements as would appear in a complete Annual Report (10-K). This initial release of periodical results fits the definition of an Earnings Release (ER). FY 2025
2026-04-13 English
Notice of FY25 Results
Report Publication Announcement Classification · 92% confidence The document is a short RNS press release (4,478 characters) titled “Notice of FY25 Results” that simply announces the date on which the full year results for the period ending 31 December 2025 will be published and provides details for a webcast and subsequent presentation release. It contains no actual financial results or detailed report content and fits the pattern of a Report Publication Announcement notifying investors of when and how the full year report will be made available.
2026-03-30 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.